The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
Generic Industry Pondering Specific Proposal to Address Unreasonable Price Rises
To read the full story
Related Article
ORGANIZATION
- JGA Targets FY2027 for Resolving Drug Shortages, Two Years Ahead of Forecast
June 20, 2025
- Generic Use Rate at 89.0% in January: Payer
June 18, 2025
- JMA’s Upper House Candidate Says Scraping Drug Prices to Pool Resources No Longer Holds
June 17, 2025
- 84% of Pharmacies See More Generic Dispensing after Rollout of New LLP Rule: FPMAJ
June 17, 2025
- FPMAJ Calls for Relaxation of Support Rules for Low-Priced Drugs
June 17, 2025
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…